TCM Reports Significant Decline in Net Sales and Profitability for December Quarter

TCM, a microcap company in the Pesticides & Agrochemicals industry, has recently reported its financial results for the quarter ending December 2024. The results indicate a notable shift in the company's financial standing, with a revision in its score reflecting the challenges faced during this period.
The financial data reveals that TCM's Debtors Turnover Ratio has reached a high of 4.45 times on a half-yearly basis, demonstrating the company's efficiency in settling its debtors more quickly over the last five half-year periods. This aspect of the business appears to be functioning well, suggesting effective management of receivables.

Conversely, the company has encountered significant hurdles, as evidenced by its net sales, which totaled Rs 6.18 crore, marking a substantial decline of 45.31% year on year. Additionally, the Profit Before Tax less Other Income (PBT) has reported a loss of Rs -0.96 crore, reflecting a drastic year-on-year decline of 247.69%. These figures indicate a challenging near-term outlook for TCM.

In light of these developments, TCM's evaluation has undergone adjustments, underscoring the complexities of its current financial landscape.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.